Upregulation of KDM6B contributes to lipopolysaccharide-induced anxiety-like behavior via modulation of VGLL4 in mice

Yangping Shentu,Qiuyun Tian,Jinge Yang,Xiaoyuan Liu,Yujiao Han,Dichen Yang,Nan Zhang,Xiaofang Fan,Ping Wang,Jianshe Ma,Ran Chen,Dantong Li,Shouting Liu,Yongyu Wang,Sunzhong Mao,Yongsheng Gong,Congkuo Du,Junming Fan

DOI: https://doi.org/10.1016/j.bbr.2021.113305

IF: 3.352

2021-06-01

Behavioural Brain Research

Abstract:<a href="/topics/neuroscience/histone">Histone</a> H3K27me3 <a href="/topics/neuroscience/demethylase">demethylase</a> KDM6B (also known as Jumonji domain-containing protein D3, JMJD3) plays vital roles in the etiology of inflammatory responses; however, little is known about the role of KDM6B in neuroinflammation-induced anxiety-like behavior. The present study aimed to investigate the potential role of KDM6B in lipopolysaccharide (LPS)-induced anxiety-like behavior and to evaluate whether it is associated with the modulation of vestigial-like family member 4 (VGLL4). The elevated plus maze, light-dark box, and open-field test were performed to test the anxiety-like behavior induced by LPS in C57BL/6 J male mice. Levels of relative <a href="/topics/neuroscience/protein-expression">protein expression</a> in the hippocampus were quantified by western blotting. KDM6B inhibitor GSK-J4 and <a href="/topics/neuroscience/microglia">microglia</a> inhibitor <a href="/topics/neuroscience/minocycline">minocycline</a> as well as adeno-associated virus of Vgll4 <a href="/topics/neuroscience/small-hairpin-rna">shRNA</a> were used to explore the underlying mechanisms. We found that KDM6B, VGLL4, interleukin-1β (IL-1β), and ionized calcium-binding adaptor molecule-1 (Iba-1, microglia marker) protein levels were increased in LPS-dose dependent manner in the hippocampus but not in prefrontal cortex. GSK-J4 treatment attenuated LPS-induced VGLL4, the <a href="/topics/neuroscience/stat3">signal transducer and activator of transcription 3</a> (STAT3), IL-1β and Iba-1 upregulation and anxiety-like behavior. Knockdown VGLL4 with Vgll4 shRNA prevented the increase of anxiety-like behavior and levels of STAT3, IL-1β, and Iba-1 expression in the hippocampus of LPS-treated mice. Moreover, minocycline, an inhibitor of microglia treatment blunted LPS-induced anxiety-like behavior. Collectively, these results demonstrate that the induction of neuroinflammation by LPS promotes KDM6B activation in the hippocampus, and LPS-induced anxiety-like behavior is associated with upregulation of VGLL4 by KDM6B in the hippocampus.

behavioral sciences,neurosciences

What problem does this paper attempt to address?

The paper aims to explore the role and potential mechanisms of histone H3K27me3 demethylase KDM6B in lipopolysaccharide (LPS)-induced anxiety-like behavior in mice. Specifically, the study attempts to answer the following questions: 1. **The relationship between KDM6B and anxiety-like behavior**: The study investigates whether KDM6B is involved in LPS-induced anxiety-like behavior by detecting changes in KDM6B and VGLL4 protein levels in the hippocampus of mice treated with different doses of LPS. 2. **The role of KDM6B inhibitors**: By using the KDM6B inhibitor GSK-J4 to treat mice, the study observes its effect on LPS-induced anxiety-like behavior, thereby verifying the role of KDM6B in neuroinflammation-related anxiety-like behavior. 3. **The role of VGLL4 in LPS-induced anxiety-like behavior**: The study evaluates the role of VGLL4 in LPS-induced anxiety-like behavior by using adeno-associated virus (AAV)-carried Vgll4 shRNA to knock down VGLL4 gene expression. 4. **The role of microglia**: By using the microglia inhibitor minocycline (MNC), the study explores the role of microglia activation in LPS-induced anxiety-like behavior. The results show that LPS can significantly increase the expression of KDM6B, VGLL4, IL-1β, and Iba-1 proteins in the hippocampus of mice, and this change is closely related to anxiety-like behavior. Additionally, inhibiting KDM6B can alleviate LPS-induced anxiety-like behavior and downregulate the expression of related proteins. These results suggest that KDM6B may promote hippocampal neuroinflammatory responses by regulating VGLL4 gene transcription, thereby leading to the occurrence of anxiety-like behavior.

Upregulation of KDM6B contributes to lipopolysaccharide-induced anxiety-like behavior via modulation of VGLL4 in mice

Systemic Inflammation Induces Anxiety Disorder Through CXCL12/CXCR4 Pathway

Dynamic Microglial Activation is Associated with LPS-induced Depressive-like Behavior in Mice: an [18F] DPA-714 PET Imaging Study

Microglial glutaminase 1 mediates chronic restraint stress-induced depression-like behaviors and synaptic damages

Hydrogen sulfide ameliorates lipopolysaccharide-induced anxiety-like behavior by inhibiting checkpoint kinase 1 activation in the hippocampus of mice

Lentivirus-mediated interleukin-1β (IL-1β) knock-down in the hippocampus alleviates lipopolysaccharide (LPS)-induced memory deficits and anxiety- and depression-like behaviors in mice

Resveratrol ameliorates lipopolysaccharide-induced anxiety-like behavior by attenuating YAP-mediated neuro-inflammation and promoting hippocampal autophagy in mice

Neuroinflammatory transcriptional signatures in the entorhinal cortex based on lipopolysaccharide-induced depression model in mice

Microglial activation in the dorsal striatum participates in anxiety-like behavior in Cyld knockout mice

BDNF gene hydroxymethylation in hippocampus related to neuroinflammation-induced depression-like behaviors in mice

Protective effect of Nr4a2 (Nurr1) against LPS-induced depressive-like behaviors via regulating activity of microglia and CamkII neurons in anterior cingulate cortex

Microglial activation results in neuron-type-specific increase in mPFC GABAergic transmission and abnormal behavior in mice

Systemic LPS-induced microglial activation results in increased GABAergic tone: A mechanism of protection against neuroinflammation in the medial prefrontal cortex in mice

Upregulation of KDM6B in the anterior cingulate cortex contributes to neonatal maternal deprivation-induced chronic visceral pain in mice

Upregulation of K+ Current in Hippocampal Neurons from Rat with Depressive-Like Behavior Induced by Lipopolysaccharide

Involvement of inflammasome activation in lipopolysaccharide-induced mice depressive-like behaviors.

PPM1F in Dentate Gyrus Modulates Anxiety-Related Behaviors by Regulating BDNF Expression via AKT/JNK/p-H3S10 Pathway

Gastrodin ameliorates the lipopolysaccharide-induced neuroinflammation in mice by downregulating miR-107-3p

Early-Life Lipopolysaccharide Exposure Potentiates Forebrain Expression of Nlrp3 Inflammasome Proteins and Anxiety-Like Behavior in Adolescent Rats

Gut microbiome-derived lactate promotes to anxiety-like behaviors through GPR81 receptor-mediated lipid metabolism pathway

Peripheral inflammation triggering central anxiety through the hippocampal glutamate metabolized receptor 1